Eden Bio

What Eden Bio does

Eden Bio, legally Eden Genetics Ltd, is a London-based biotechnology company founded in 2021 that builds a machine learning platform for optimizing the genetic engineering of microorganism strains used in precision fermentation. The company claims its platform achieves a 2-3 fold improvement in protein yields compared with conventional strain generation methods, and positions the offering as serving companies in food, pharmaceutical, and biofuel production that require scalable, cost-efficient protein manufacturing. Its core product is a single AI-driven platform that combines genetic optimization with precision fermentation, targeting improved economics for sustainable protein production. Eden Bio operates as a B2B enterprise selling to industrial customers in three verticals; pricing is not publicly disclosed and inbound engagement is handled through a generic enquiries inbox. The company has raised £1 million in seed funding (November 2022) led by SynBioVen with Dhyana Capital, Saras Capital, and Unruly Capital, and operates with a team of 1-10 employees from its registered office in St John's Wood, London.

Name

Eden Bio

Legal name

Eden Genetics Ltd

Website

https://eden.bio

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Short description

Eden Bio (Eden Genetics Ltd) is a London-based biotech using a machine learning platform to genetically optimize microorganism strains for precision fermentation, claiming 2-3x protein yield gains for food, pharmaceutical, and biofuel producers.

Ownership category

akta.pro rank

Product category

Precision Fermentation Technology

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

AI/ML-Enabled Biologic Discovery Platforms (computational design, in silico screening) (HLAAAIAE)

akta.pro secondary industries

Protein Engineering & Directed Evolution Platforms (enzyme/therapeutic protein optimization) (HLAAAIAC), Enzymes & Industrial Biotechnology Inputs (Enzymes, Microbial Strains, Fermentation Aids) (EUAAAIAL)

Keywords

• Precision fermentation technology
• Protein yield optimization
• AI strain engineering
• Microorganism genetic optimization
• Biotech protein production

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. AI Platform Licensing/Technology Services: Eden Bio appears to generate revenue through licensing its AI-driven genetic optimization technology to companies in food, pharmaceutical, and biofuels industries. The company provides precision fermentation technology services to support sustainable protein production.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Eden Bio provides an AI-driven platform that uses machine learning to genetically optimize microorganism strains for precision fermentation, achieving 2-3 fold improvements in protein yields. The platform is sold to enterprise customers in the food, pharmaceutical, and biofuels industries to enable scalable, cost-effective sustainable protein production.

Product overview

Eden Bio (also operating as Eden Genetics Ltd) provides an AI-driven platform for scalable protein production through precision fermentation. The company's single unified offering combines machine learning technology with genetic engineering to optimize microorganism strains, achieving 2-3 fold improvements in protein yields. Their platform serves the food, pharmaceuticals, and biofuels industries, focusing on reducing production costs through genetically optimized strains.

Differentiator

Problem solved

Functional benefit

Products and services

• AI-Driven Protein Production Platform

Quantifiable outcome

• 2-3 fold improvement in protein yield

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature2 records

Scale indicators1 record

Recent moves3 records

Expansion highlights3 records

Direct peers

• Cradle: Cradle applies machine learning to protein engineering and bioprocess optimization, including for food, pharma, and industrial biotech customers. Highly comparable to Eden Bio as a direct competitor in AI-driven protein/strain design with a similar B2B, cross-vertical GTM.
• Bota Bio: Bota Bio builds an AI-driven biomanufacturing platform for strain engineering and precision fermentation across specialty ingredients. Directly comparable business model: ML-optimized microbial strains used to produce proteins and chemicals more efficiently for industrial customers.
• Profluent: Profluent uses AI/deep learning models to design novel proteins and engineer biology. Comparable to Eden Bio's AI-driven approach to protein design, though broader in scope, providing competitive positioning at the intersection of ML and synthetic biology.
• Culture Biosciences: Culture Biosciences operates a cloud-based fermentation services platform helping companies optimize microbial strains and bioprocesses. Comparable because it serves the same biomanufacturing customer base seeking higher-yield, lower-cost fermentation, though more services-led than Eden Bio's pure-AI platform.
• ZymoChem: ZymoChem develops microbes and bioprocesses for cost-competitive biomanufacturing of chemicals and materials using AI-guided strain engineering. Directly comparable as an early-stage AI/strain engineering company targeting industrial customers with a yield-and-cost optimization thesis.

Broad incumbents

• Ginkgo Bioworks: Ginkgo Bioworks is a large, established cell engineering platform serving food, pharma, and industrial biotech customers. Comparable as a broad incumbent in the same precision fermentation programming space, though with deeper pockets, more partners, and a much larger platform offering than Eden Bio's focused yield-optimization tool.
• LanzaTech: LanzaTech is an established carbon-eating gas fermentation company developing fuels and chemicals via optimized microbial processes. Comparable as a broad incumbent in microbial bioprocess optimization with biofuels overlap to Eden Bio's biofuels vertical, but at much larger industrial scale.
• Inscripta (now known as Inari): Inari applies computational design to seed and agricultural biotechnology, combining AI/ML with biology. Comparable emerging-but-broader player in computational biology for agriculture and industrial biotech, providing overlap to Eden Bio's strain engineering approach for food/ag-adjacent applications.

Emerging players

• Arcaea (formerly known as Sundial Foods / merged entity): Arcaea is an early-stage platform combining AI, genomics, and protein engineering to build new ingredients for beauty, food, and personal care. Comparable as an AI-driven protein/ingredient engineering company at early stage, overlapping with Eden Bio's food vertical and protein yield focus.

Others

• Mendel Biotechnology / BioConsortia: BioConsortia develops advanced microbial products for agriculture and bioprocessing using microbial selection and computational biology. Adjacent/ecosystem participant using computational biology to engineer microbe-based products for industrial customers with partial overlap to Eden Bio's strain optimization thesis.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds1 record

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Eden Bio